Spencer Kobren Interviews Replicel’s CEO Havid Hall about the Interim Analysis of Data From The Company’s First-in-man TS001-2009 Clinical Trial
Spencer Kobren Interviews Replicel’s CEO Havid Hall about the Interim Analysis of Data From The Company’s First-in-man TS001-2009 Clinical Trial
One Comment
You must be logged in to post a comment.
at 10:24 am
Great interview.
Best regards,
Hans J.Diks
The Netherlands